Across the nave cohorts, 76% of tirzepatide and semaglutide initiators had 1 fill for an antihyperglycemic medication (other than a GLP-1 RA) over the 6-month pre-index period
for semaglutide, liraglutide and dulaglutide, no dose adjustment is generally required, but monitor in severe renal impairment, especially with gastrointestinal losses Pregnancy and breastfeeding: GLP-1 therapies are not recommended during pregnancy
But these were originally developed to treat diabetes
GLP-1 The Best Weight Loss Medication in the U.S
Lower prices can make a real difference, but the support around the prescription still matters. For many patients, the affordability challenge does not end with insurance
Its important to work with a doctor and monitor symptoms to ensure correct dosing, Dr